Emcure Pharma Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth of 12.05% QoQ in the latest quarter signals robust demand.
Net profit increased by 37.5% compared to the previous quarter, reflecting improved cost management.
Operating profit margin improved to 13.83%, indicating efficiency gains and better pricing strategies.

NEGATIVES

Revenue declined by 1.92% from the previous quarter, raising concerns about sales momentum.
Other income significantly dropped to 0.20%, suggesting reliance on core operations.
Material costs increased marginally, which could pressure margins if trends continue.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	1,556.16	1,663.09	1,667.64	1,771.36	1,815.14	2,001.98	1,962.63	2,116.24	2,100.54
Expenses	1,260.55	1,334.05	1,360.70	1,460.68	1,478.46	1,621.11	1,608.02	1,713.85	1,683.76
Operating Profit	295.61	329.04	306.94	310.67	336.67	380.87	354.61	402.40	416.77
Other Income	14.98	1.33	15.72	12.42	23.08	35.65	3.90	4.45	3.70
Interest	52.07	58.94	60.65	65.49	58.76	46.22	31.78	39.02	26.76
Depreciation	67.17	70.28	84.39	90.56	93.59	96.90	96.81	96.84	99.46
Profit Before Tax	191.34	198.03	170.96	166.90	207.41	273.41	229.92	260.61	290.76
Tax	50.38	52.19	51.20	45.89	54.82	71.86	73.83	63.38	75.97
Net Profit	140.97	145.84	119.76	121.02	152.59	201.55	156.09	197.24	214.79
Eps in Rs	7.21	7.70	6.27	6.36	7.95	10.33	8.12	9.97	10.92